The Research and Development team at Shape Therapeutics focuses on pioneering RNA-targeted therapies through cutting-edge scientific research, platform technology innovations, and robust preclinical development. They drive the discovery and optimization of novel therapeutic candidates, manage clinical research efforts, and streamline program and portfolio management to advance treatments for complex diseases.
Adrian W Briggs
VP, Head of Platform Technolog...
Andrew Dietz
Vice President, Clinical Resea...
Brian Booth
Director, Platform Technologie...
Karyn Huryn-Selvar
Associate Director, Lab and Fa...
Marsha Mason
Associate Director, Program an...
Rafael Ponce
EVP, Preclinical Development
Ron Hause
VP, Head of Analytics and Info...
View all